Anabolic growth factors, including platelet derived growth factor (PDGF) and insulin-like growth factor-1 (IGF-1), are concentrated in APS and act in concert to decrease IL-1β-induced NF-κβ activation (Montaseri et al. 2011). This evidence concerns the gene NFKB1 and autoimmune polyendocrinopathy.